Foyen has assisted 3iM Equity Partners in the sale of Allderma AB.
Allderma is active in the over-the-counter pharmaceuticals market and has, since its acquisition by 3iM in 2020, experienced strong growth driven by product innovation, geographical expansion, and complementary acquisitions. 3iM's strategy is to invest in and develop niche-leading companies in Consumer Healthcare in the Nordic region.
Foyen’s team has primarily consisted of Jonas Conradsson and Moa Lindholm.
/R%C3%84TT%20FORMAT%20Medarbetare%20Foyen%20(kvadratiska)/Jonas%20Conradsson%201620x1620px.jpg?width=800&height=800&name=Jonas%20Conradsson%201620x1620px.jpg)
/Bildbank%20webb%201500px/Foyen_webb_energi_innovation_med_tech_1500px_ny.jpg?width=1920&name=Foyen_webb_energi_innovation_med_tech_1500px_ny.jpg)
/R%C3%84TT%20FORMAT%20Medarbetare%20Foyen%20(kvadratiska)/Moa%20Lindholm%201620x1620px.jpg?width=800&height=800&name=Moa%20Lindholm%201620x1620px.jpg)